Last reviewed · How we verify

NCT05914779

Impact of Early Antibiotics on Non-Traumatic Out of Hospital Cardiac Arrest (OHCA)

Recruiting now NA Last updated 3 April 2025
What this trial tests

NA trial testing No use of antibiotics in Infection, Bacterial in 1,000 participants. Currently enrolling.

Timeline
1 March 2023
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorHamad Medical Corporation
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment1,000
Start date1 March 2023
Primary completion31 December 2025
Estimated completion31 December 2025
Sites1 location across Qatar

Drugs / interventions tested

Conditions studied

Sponsor

Hamad Medical Corporation — full company profile →

Who can join

18 and older, any sex, with Infection, Bacterial or Out-Of-Hospital Cardiac Arrest. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Specific Aim : The specific aim is to conduct a randomized prospective clinical trial to determine whether no antibiotics in OHCA patients in the ED with very low likelihood of infection is non-inferior to early antibiotic treatment. Hypothesis a: 28-day all-cause mortality will be non-inferior in OHCA patients with very low likelihood of infection who do not receive antibiotic therapy compared with those who receive early antibiotic therapy Hypothesis b: There will be no difference in subsequent incidence of proven infections in the no antibiotics vs, early antibiotics groups Hypothesis c: There will be no difference in the length of ICU stay and overall hospital stay in the early antibiotics vs. no antibiotics groups

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Infection, Bacterial

Currently open trials in the same condition.

Other Hamad Medical Corporation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05914779.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing